Executive Orders Bolster USD/JPY, But Peso Ends up On Top in Trump/Pena Tussle

Executive Orders Bolster USD/JPY, But Peso Ends up On Top in Trump/Pena Tussle

The U.S. dollar closed out the week mixed against the major currencies as financial markets debated the impact on the dollar by executive orders signed by President Trump aimed at increasing infrastructure spending, rising tensions between Trump and Mexican President Enrique Pena Nieto, and a UK high court’s decision regarding the country’s divorce from the European Union. The Dow Jones Industrial Average finally crossed over the elusive 20,000 milestone this […]

Read More ˃
Shares of Comstock Holding Companies, Inc. (NASDAQ:CHCI) Up Following Announcement of Joint Venture at Shady Grove Metro

Shares of Comstock Holding Companies, Inc. (NASDAQ:CHCI) Up Following Announcement of Joint Venture at Shady Grove Metro

Wholly-owned subsidiary of Comstock Holding Companies, Inc. (NASDAQ:CHCI), Comstock Homes of Washington, LC, announces that it will partner with Stratford Capital Group on Washington D.C.’s Shady Grove Metro Station. WASHINGTON and RESTON, Va., Nov. 14, 2016 /PRNewswire/ — Comstock Homes of Washington, LC, a wholly owned subsidiary of Comstock Holding Companies, Inc. (CHCI), announced that it will partner with Stratford Capital Group on a multifamily project located at the Shady […]

Read More ˃
iPass Inc. (NASDAQ:IPAS)’s Shares on the Decline Following Reports of Third Quarter 2016 Financial Loss

iPass Inc. (NASDAQ:IPAS)’s Shares on the Decline Following Reports of Third Quarter 2016 Financial Loss

Leading provider of global mobile connectivity, iPass Inc. (NASDAQ:IPAS), releases Q3, 2016 financial report. REDWOOD SHORES, CA–(Marketwired – Nov 3, 2016) – iPass Inc. ( NASDAQ : IPAS ), the leading provider of global mobile connectivity, reported total revenue of $15.9 million, GAAP net loss of $1.3 million, and Adjusted EBITDA loss of $0.4 million for the quarter ended September 30, 2016. “The third quarter exemplified our previous commentary on […]

Read More ˃
Tandem Diabetes Care, Inc. (NASDAQ:TNDM)’s Shares Tank After Reports of 3Q Loss

Tandem Diabetes Care, Inc. (NASDAQ:TNDM)’s Shares Tank After Reports of 3Q Loss

Medical device company, Tandem Diabetes Care, Inc. (NASDAQ:TNDM), reports losses of $29.8 million in Q3, 2016. SAN DIEGO (AP) _ Tandem Diabetes Care Inc. (TNDM) on Tuesday reported a loss of $29.8 million in its third quarter. The San Diego-based company said it had a loss of 97 cents per share. The results fell short of Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research […]

Read More ˃
Shares of Violin Memory, Inc. (NYSE:VMEM) Take a Hit as it Transfers to OTC Markets Group, Int.

Shares of Violin Memory, Inc. (NYSE:VMEM) Take a Hit as it Transfers to OTC Markets Group, Int.

Designer and distributor or data storage, Violin Memory, Inc. (NYSE:VMEM), announces that it has qualified to trade on the OTCQX Best Market, transferring from the New York Stock Exchange (NYSE). NEW YORK, Oct. 28, 2016 /PRNewswire/ — OTC Markets Group Inc. (OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Violin Memory, Inc. (VMEM), a company that designs and distributes data storage hardware and software, has […]

Read More ˃
Giga-tronics, Inc. (NASDAQ:GIGA) Will Announce Q2 Earnings at Conference Call on November 7, 2016.  How Will This Affect the Share Price?

Giga-tronics, Inc. (NASDAQ:GIGA) Will Announce Q2 Earnings at Conference Call on November 7, 2016. How Will This Affect the Share Price?

Giga-tronics, Inc. (NASDAQ:GIGA) announces that they will release its second-quarter results for the second quarter of fiscal year 2017 on November 7th. SAN RAMON, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) — Giga-tronics Incorporated (GIGA) will release results for the second quarter of fiscal year 2017 on Monday November 7, 2016 after the close of trading on the NASDAQ Capital Market. Also on November 7, 2016, Giga-tronics will host a conference […]

Read More ˃
Shares of Violin Memory, Inc. (NYSE:VMEM) Advance Upon News of Support Expansion

Shares of Violin Memory, Inc. (NYSE:VMEM) Advance Upon News of Support Expansion

Global pioneer of award-winning flash storage solutions, Violin Memory, Inc. (NYSE:VMEM), announces availability of new block storage driver. SANTA CLARA, CA–(Marketwired – October 25, 2016) – Violin Memory®, Inc., (VMEM) a global pioneer of award-winning all flash storage platform solutions for primary storage and active workloads, today announced availability of a Block Storage (Cinder) driver supporting the Red Hat OpenStack Platform 8 (Liberty release). The driver supports the OpenStack Liberty […]

Read More ˃
Legacy Reserves, LP (NASDAQ:LGCY)’s Shares on the Rise After Disclosure of ‘Not Cheap But Needed’ Second Lien Term Loan

Legacy Reserves, LP (NASDAQ:LGCY)’s Shares on the Rise After Disclosure of ‘Not Cheap But Needed’ Second Lien Term Loan

Oil and natural gas properties developer, Legacy Reserves, LP (NASDAQ:LGCY), discloses second lien term loan of $300 million. A day after Legacy Reserves LP (NASDAQ: LGCY) disclosed second lien term loan of a maximum of $300 million, Stifel termed it as “not cheap.” However, the firm thinks the company needed it badly. Following the move, analyst Brian Brungardt upgraded the stock from Sell to Hold and boosted the target price […]

Read More ˃
How Will Ocera Therapeutics, Inc. (NASDAQ:OCRX)’s Share Price Respond to Announcement of News That Late-Breaker Abstract Accepted for Presentation

How Will Ocera Therapeutics, Inc. (NASDAQ:OCRX)’s Share Price Respond to Announcement of News That Late-Breaker Abstract Accepted for Presentation

Clinical-stage biopharmaceutical company, Ocera Therapeutics, Inc. (NASDAQ:OCRX), announced that it will release clinical trial data at the Liver Meeting 2016, November 11-15, 2016, in Boston. PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2016 (GLOBE NEWSWIRE) — Ocera Therapeutics, Inc. (OCRX), today announced that clinical data from STOP-ALF, a Phase 2a clinical trial to evaluate the Safety and Tolerability of Ornithine Phenylacetate (OCR-002) in patients with Acute Liver […]

Read More ˃
Pluristem Therapeutics, Inc. (NASDAQ:PSTI)’ Shares on the Rise After Signing $30 Million Term Sheet

Pluristem Therapeutics, Inc. (NASDAQ:PSTI)’ Shares on the Rise After Signing $30 Million Term Sheet

Leading developer of placenta-based cell therapy products, Pluristem Therapeutics, Inc. (NASDAQ:PSTI), announced that it has signed a term sheet for an investment of $30M by China-based Innovative Medical Management Co. HAIFA, Israel, Oct. 25, 2016 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (PSTI)(PSTI), a leading developer of placenta-based cell therapy products, today announced it has signed a term sheet for an investment of approximately $30,000,000 by China-based Innovative Medical Management Co., […]

Read More ˃